The clinical evidence overwhelmingly favors semaglutide for meaningful fat reduction, but the nearly nonexistent side effect profile of AOD 9604 gives it a unique position for specific use cases
This is known in medicine as secondary dysmenorrhea, because the menstrual cramps, often severe, are caused by something besides menstruation
Biohacking culture People want to optimize performance and longevity Social media influence Peptides are widely promoted as recovery shortcuts Frustration with slow healing = lack of education by providers on how long tendon/ligament injuries can take to repair Athletes often seek ways to speed recovery beyond natural timelines A Major Concern: Unregulated Products Currently: most peptides are not approved by Health Canada or the FDA manufacturing is largely unregulated quality control is inconsistent This makes it difficult to verify: product purity dosing accuracy contamination risk Current Medical Consensus Peptides show biological promise in preclinical research but lack sufficient human evidence for routine clinical use Important unknowns include: dosing frequency duration long-term safety How Group23 Approaches Regenerative Medicine At Group23 Sports Medicine, we focus on treatments supported by the strongest evidence: structured rehabilitation programs under physiotherapy supervision load management and strength training ideally with strength and conditioning coach platelet-rich plasma (PRP) soft tissue adapted biocompatible hyaluronic acid injections SportVis see www.sportvis.ca high molecular weight cross linked hyaluronic acid injections Monovisc (see www.monovisc.ca), Synolis VA (see www.synolis.com) and Durolane (www.durolane.ca/en/) Blood Flow Restriction (BFR) therapy (see off the shelf and custom bracing strategies These treatments currently have far stronger clinical evidence than experimental peptide therapies
Furthermore, apoptosis induced via either chromium (VI) [76] or LPS [77] also protected by Nrf2-dependent HO-1 induction
But what is the difference between the two
This intense exercise, characterized by short spurts, has been shown to improve hepatic steatosis and cardiac function in MASLD patients [39]
